Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

CHOLESTEROLEMIE --- DYSLIPIDEMIES --- ANTIHYPERTENSEURS --- POLYAMINES NATURELLES --- IMMUNITAIRE (SYSTEME) ET POLYAMINES --- QUINAZOLONES --- INTERFERONS : PRODUCTION AND ACTION --- NATURAL PRODUCTS AS ANTICANCER AGENTS --- ANTICANCER AGENTS --- CHOLESTEROL --- CHOLESTEROL : HIGH CHOLESTEROL BLOOD LEVELS --- ANTIHYPERTENSIVE AGENTS --- POLYAMINES (NATURAL) --- PDR 42 --- BLOOD --- THERAPEUTIC USE

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact

Science: general issues --- Supramolecular coordination complexes --- Metallacages --- helicates --- Anticancer agents --- host-guest chemistry --- Drug delivery --- Antibacterial Agents

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Biogenic Nanoparticles for Cancer Theranostics outlines the synthesis of biogenic nanoparticles to become cancer theranostic agents. The book also discusses their cellular interaction and uptake, pharmacokinetics, biodistribution, drug delivery efficiency, and other biological effects. Additionally, the book explores the mechanism of their penetration in cancerous tissue, its clearance, and its metabolism. Moreover, the in vitro and in vivo toxicological effects of biogenic nanoparticles are discussed. This book is an important reference source for materials scientists and biomedical scientists who are looking to increase their understanding of how biogenic nanoparticles are being used for a range of cancer treatment types.

Neoplasms --- Antineoplastic agents. --- Anticancer agents --- Antineoplastic drugs --- Antineoplastics --- Antitumor agents --- Antitumor drugs --- Cytotoxic drugs --- Inhibitors, Neoplasm --- Neoplasm inhibitors --- Drugs --- Cancer --- Tumours --- Pathology --- Cysts (Pathology) --- Oncology --- drug therapy. --- Chemotherapy

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Carcinogenicity. --- Anticancer agents --- Cancer preventing --- Drug research : management --- Drug research :organization --- Estrogen-opiate hybrids --- Flavonoids and cancer preventing --- Luteinizing hormone --- Management qualifications in pharmacy --- Managers in pharmacy : stress --- Mutagenicity --- Natural products as anticancer agents --- Oestrogenes --- Opiates --- Serenics --- Transfer factor 1993 --- Transfer factor in malignancy

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Emerging as an important new volume in the renowned Cancer Drug Discovery and Development™ series, Deoxynucleoside Analogs in Cancer Therapy expertly summarizes the current status of development and application of deoxynucleoside analogs. Authoritative up-to-date reviews are presented by scientists well known in their specific areas and all contributions include valuable sound advice on structure and topics. Organized into several sections, the first part covers general aspects of drug uptake and metabolism and explains how novel technology has enabled a rapid expansion of this field. The second part is concerned with a number of specific drugs including cytarabine, gemcitabine, troxacitabine, clofarabine and Ara-G. The final section covers pharmacokinetics, prodrugs, and specific applications such as radiosensitization, gene therapy, and the use of deoxynucleoside analogs as tracers. Throughout Deoxynucleoside Analogs in Cancer Therapy, the focus is on novel aspects of deoxynucleoside analogs in the clinical context, as well as on unexpected targets of these compounds, such as their specific activity against cell cycle-dependent kinases or oncogenes. The wealth of information presented here can be used to design rational combinations aimed at inhibiting various cellular signaling pathways, or combining inhibition of various targets. Deoxynucleoside Analogs in Cancer Therapy has been designed specifically to facilitate such an interaction between various fields.

Deoxyribonucleotides --- Antineoplastic agents. --- Cancer --- Anticancer agents --- Antineoplastic drugs --- Antineoplastics --- Antitumor agents --- Antitumor drugs --- Cytotoxic drugs --- Inhibitors, Neoplasm --- Neoplasm inhibitors --- Ribonucleotides, Deoxy --- Therapeutic use. --- Chemotherapy. --- Medicine. --- Cancer research. --- Biomedicine. --- Cancer Research. --- Drugs --- Nucleotides --- Antineoplastic agents --- Chemotherapy --- Treatment